What could be better, or worse, than a smartphone health app to help diagnose over 60 diseases? The FDA has given us all time to opine on this by questioning a healthcare app kit manufacturer’s authority to offer its smartphone-linked kit for sale in the US without regulatory clearance. As a result of the FDA’s inquiry, the company in question, Biosense Technologies Private Ltd., is now attempting to raise funds via crowdfunding (a pre-order sales option) to comply with eventual FDA standards and regulations. Read the details here.
Menu
Visit our website
New America Cypbersecurity Initiative
MIT Technology Review
io9
Techdirt
Knowledge@Wharton
Bioscience Technology
redOrbit
Technology & Marketing Law Blog
Popular Science Blog
Pew Research Center
Genomics Law Report
Science 2.0
The Guardian Headquarters
Genetic Literacy Project
Disclaimer
Statements posted on this blog represent the views of individual authors and do not necessarily represent the views of the Center for Law Science & Innovation (which does not take positions on policy issues) or of the Sandra Day O'Connor College of Law or Arizona State University.